2-arachidonoyl glycerol and 2-Arachidonoylglycerol: Difference between pages
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
'''2- |
'''2-Arachidonoylglycerol''' (2-AG) is an endogenous [[agonist]] of the [[CB1 receptor]].[1],[2] Unlike [[anandamide]], 2-AG is present at relatively high levels in the central nervous system; it is the most abundant molecular species of [[monoacylglycerol]] found in rat brain.[1],[3] Formation of 2-AG is calcium-dependent and is mediated by the activities of [[phospholipase C]] (PLC) and [[diacylglycerol lipase]] (DAG).[1] 2-AG acts as a full agonist at the CB1 receptor. At a concentration of 0.3 nM, 2-AG induces a rapid, transient increase in intracellular free calcium in NG108-15 [[neuroblastoma]] X glioma cells through a CB1 receptor-dependent mechanism.[2] 2-AG is metabolized in vitro by [[monoacylglycerol lipase]] (MGL) and [[fatty acid amide hydrolase]], with MGL likely being the principle metabolizing enzyme in vivo.[4] |
||
== References == |
== References == |
||
# Stella, N., Schweitzer, P., Piomelli, D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 773-778 (1997). |
# Stella, N., Schweitzer, P., Piomelli, D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 773-778 (1997). |
||
Line 9: | Line 7: | ||
# Kondo, S., Kondo, H., Nakane, S., et al. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: Identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+-dependent and -independent mechanisms. FEBS Lett 429 152-156 (1998). |
# Kondo, S., Kondo, H., Nakane, S., et al. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: Identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+-dependent and -independent mechanisms. FEBS Lett 429 152-156 (1998). |
||
# Dinh, T.P., Carpenter, D., Leslie, F.M., et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99(16) 10819-10824 (2002). |
# Dinh, T.P., Carpenter, D., Leslie, F.M., et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99(16) 10819-10824 (2002). |
||
== External links == |
|||
[http://www.caymanchem.com/app/template/Product.vm/catalog/62160/promo/searchresult.62160/a/z] |
Revision as of 17:56, 16 November 2006
2-Arachidonoylglycerol (2-AG) is an endogenous agonist of the CB1 receptor.[1],[2] Unlike anandamide, 2-AG is present at relatively high levels in the central nervous system; it is the most abundant molecular species of monoacylglycerol found in rat brain.[1],[3] Formation of 2-AG is calcium-dependent and is mediated by the activities of phospholipase C (PLC) and diacylglycerol lipase (DAG).[1] 2-AG acts as a full agonist at the CB1 receptor. At a concentration of 0.3 nM, 2-AG induces a rapid, transient increase in intracellular free calcium in NG108-15 neuroblastoma X glioma cells through a CB1 receptor-dependent mechanism.[2] 2-AG is metabolized in vitro by monoacylglycerol lipase (MGL) and fatty acid amide hydrolase, with MGL likely being the principle metabolizing enzyme in vivo.[4]
References
- Stella, N., Schweitzer, P., Piomelli, D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 773-778 (1997).
- Sugiura, T., Kodaka, T., Nakane, S., et al. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J Biol Chem 274 2794-2801 (1999).
- Kondo, S., Kondo, H., Nakane, S., et al. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: Identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+-dependent and -independent mechanisms. FEBS Lett 429 152-156 (1998).
- Dinh, T.P., Carpenter, D., Leslie, F.M., et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99(16) 10819-10824 (2002).